Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 17Hodgkin Disease 15Central Nervous System Neoplasms 12Astrocytoma 8Oligodendroglioma 7Brain Neoplasms 7Gliosarcoma 5Glioblastoma 5Glioma 4Lymphoma, Non-Hodgkin 3Neurotoxicity Syndromes 2Lymphoma, Follicular 2Lymphoma, AIDS-Related 2Recurrence 1Radiation Injuries 1Optic Nerve Glioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Intraocular Lymphoma 1HIV Infections 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Ataxia Telangiectasia 1Ataxia 1

Interventions

Cyclophosphamide 67Dexamethasone 52Peripheral Blood Stem Cell Transplantation 37Lenalidomide 37Rituximab 35fludarabine phosphate 34Bortezomib 30Filgrastim 27Etoposide 27Cytarabine 25Carboplatin 25Busulfan 23Radiotherapy 22Melphalan 22Gemcitabine 22Cyclosporine 21pomalidomide 20fludarabine 20Whole-Body Irradiation 20Mycophenolic Acid 20Paclitaxel 19Methotrexate 18venetoclax 17Cisplatin 17pembrolizumab 16Calcium Dobesilate 16Bevacizumab 16Tacrolimus 14Antilymphocyte Serum 14Nivolumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Recurrence × Procarbazine × Clear all
NCT00574496 2023-09-28

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
25 enrolled 10 charts
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡